Literature DB >> 12010933

Comparison of permanent left ventricular and biventricular pacing in patients with heart failure and chronic atrial fibrillation: prospective haemodynamic study.

S Garrigue1, P Bordachar, S Reuter, P Jaïs, A Kobeissi, G Gaggini, M Haïssaguerre, J Clementy.   

Abstract

OBJECTIVE: To compare clinical and haemodynamic variables between left ventricular and biventricular pacing in patients with severe heart failure; and to analyse haemodynamic changes during daily life and maximum exercise during chronic left ventricular and biventricular pacing.
DESIGN: Prospective single blinded randomised study with crossover.
SETTING: University hospital (tertiary referral centre). PATIENTS AND METHODS: 13 patients (mean (SD) age, 62 (6) years) with chronic atrial fibrillation, severe heart failure (mean ejection fraction 24 (8)%), and QRS prolongation of > or = 140 ms had His bundle ablation and installation of a pacemaker providing left ventricular and biventricular pacing. The pacemaker was equipped with a peak endocardial acceleration (PEA) sensor. The PEA pattern was used as a haemodynamic marker during exercise as it is highly correlated with left ventricular dP/dt. After a baseline period of right ventricular pacing, all patients had two months of left ventricular pacing and two months of biventricular pacing in random order. At the end of each phase, an echocardiogram, a haemodynamic analysis at rest and on exercise during a six minute walk test, and a cardiopulmonary exercise test were performed.
RESULTS: PEA values were higher with left ventricular pacing (0.58 (0.38) m/s) and biventricular pacing (0.62 (0.24) m/s) than at baseline (0.49 (0.18) m/s) (p < 0.05). The six minute walk test showed similar performance in both pacing modes, but patients had more symptoms with left ventricular pacing at the end of the test (p = 0.035). On cardiopulmonary exercise testing, there was a greater increase in mean percentage variation of PEA with biventricular pacing than with left ventricular pacing (125 (18)% v 97 (36)%, respectively; p = 0.048) and better performance figures (92 (34) W v 77 (23) W; p = 0.03).
CONCLUSIONS: During symptom limited and daily life exercise tests, chronic biventricular pacing provides better haemodynamic performance than left ventricular pacing. In heart failure patients with wide QRS complexes, the interventricular dyssynchronisation induced by left ventricular pacing may impair myocardial function during exercise.

Entities:  

Mesh:

Year:  2002        PMID: 12010933      PMCID: PMC1767120          DOI: 10.1136/heart.87.6.529

Source DB:  PubMed          Journal:  Heart        ISSN: 1355-6037            Impact factor:   5.994


  15 in total

1.  Biventricular pacing in end-stage heart failure improves functional capacity and left ventricular function.

Authors:  P F Bakker; H W Meijburg; J W de Vries; M M Mower; A C Thomas; M L Hull; E O Robles De Medina; J J Bredée
Journal:  J Interv Card Electrophysiol       Date:  2000-06       Impact factor: 1.900

Review 2.  Sample size requirements in cohort and case-control studies of disease.

Authors:  J J Schlesselman
Journal:  Am J Epidemiol       Date:  1974-06       Impact factor: 4.897

3.  Improved left ventricular mechanics from acute VDD pacing in patients with dilated cardiomyopathy and ventricular conduction delay.

Authors:  D A Kass; C H Chen; C Curry; M Talbot; R Berger; B Fetics; E Nevo
Journal:  Circulation       Date:  1999-03-30       Impact factor: 29.690

4.  The Pacing Therapies for Congestive Heart Failure (PATH-CHF) study: rationale, design, and endpoints of a prospective randomized multicenter study.

Authors:  A Auricchio; C Stellbrink; S Sack; M Block; J Vogt; P Bakker; P Mortensen; H Klein
Journal:  Am J Cardiol       Date:  1999-03-11       Impact factor: 2.778

5.  Evaluation of left ventricular based pacing in patients with congestive heart failure and atrial fibrillation.

Authors:  Y Etienne; J Mansourati; M Gilard; V Valls-Bertault; J Boschat; D G Benditt; K G Lurie; J J Blanc
Journal:  Am J Cardiol       Date:  1999-04-01       Impact factor: 2.778

6.  An implantable intracardiac accelerometer for monitoring myocardial contractility. The Multicenter PEA Study Group.

Authors:  A F Rickards; T Bombardini; G Corbucci; G Plicchi
Journal:  Pacing Clin Electrophysiol       Date:  1996-12       Impact factor: 1.976

7.  Left ventricular or biventricular pacing improves cardiac function at diminished energy cost in patients with dilated cardiomyopathy and left bundle-branch block.

Authors:  G S Nelson; R D Berger; B J Fetics; M Talbot; J C Spinelli; J M Hare; D A Kass
Journal:  Circulation       Date:  2000-12-19       Impact factor: 29.690

8.  Evaluation of different ventricular pacing sites in patients with severe heart failure: results of an acute hemodynamic study.

Authors:  J J Blanc; Y Etienne; M Gilard; J Mansourati; S Munier; J Boschat; D G Benditt; K G Lurie
Journal:  Circulation       Date:  1997-11-18       Impact factor: 29.690

9.  Regional effects of myocardial ischemia on epicardially recorded canine first heart sounds.

Authors:  J C Wood; M P Festen; M J Lim; A J Buda; D T Barry
Journal:  J Appl Physiol (1985)       Date:  1994-01

10.  Acute hemodynamic effects of biventricular DDD pacing in patients with end-stage heart failure.

Authors:  C Leclercq; S Cazeau; H Le Breton; P Ritter; P Mabo; D Gras; D Pavin; A Lazarus; J C Daubert
Journal:  J Am Coll Cardiol       Date:  1998-12       Impact factor: 24.094

View more
  15 in total

1.  Comparison of the haemodynamics of different pacing sites in patients undergoing resynchronisation treatment: need for individualisation of lead localisation.

Authors:  C M C van Campen; F C Visser; C C de Cock; H S Vos; O Kamp; C A Visser
Journal:  Heart       Date:  2006-06-27       Impact factor: 5.994

2.  FDG PET as a predictor of response to resynchronisation therapy in patients with ischaemic cardiomyopathy.

Authors:  C M C van Campen; Frans C Visser; Arno P van der Weerdt; Paul Knaapen; Emile F I Comans; Adriaan A Lammertsma; Carel C de Cock; Cees A Visser
Journal:  Eur J Nucl Med Mol Imaging       Date:  2006-09-26       Impact factor: 9.236

Review 3.  CRT-D therapy in patients with left ventricular dysfunction and atrial fibrillation.

Authors:  Frank Pelosi; Fred Morady
Journal:  Ann Noninvasive Electrocardiol       Date:  2005-10       Impact factor: 1.468

4.  Long-term follow-up of cardiac resynchronization therapy: mechanical resynchronization and reverse left ventricular remodeling are predictive for long-term transplant-free survival.

Authors:  Lothar Faber; Marios Vlachojannis; Olaf Oldenburg; Detlef Hering; Nicola Bogunovic; Dieter Horstkotte; Barbara Lamp
Journal:  Int J Cardiovasc Imaging       Date:  2011-10-01       Impact factor: 2.357

5.  Echocardiography-based optimization of cardiac resynchronization therapy in patients with congestive heart failure and conduction disorders.

Authors:  L Faber
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2006

6.  Recent advances in the application of computational mechanics to the diagnosis and treatment of cardiovascular disease.

Authors:  Juan C Del Alamo; Alison L Marsden; Juan C Lasheras
Journal:  Rev Esp Cardiol       Date:  2009-07       Impact factor: 4.753

Review 7.  Advances in devices for cardiac resynchronization in heart failure.

Authors:  Chu-Pak Lau; Serge Barold; Hung-Fat Tse; Kathy Lai-Fun Lee; Hon-Wah Chan; Katherine Fan; Elaine Chau; Cheuk-Man Yu
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

Review 8.  Cardiac resynchronization: a brief synopsis part I: patient selection and results from clinical trials.

Authors:  David M Kalinchak; Mark H Schoenfeld
Journal:  J Interv Card Electrophysiol       Date:  2003-10       Impact factor: 1.900

9.  [New technologies in the optimization of CRT programming].

Authors:  A Kloppe; B Lemke; M Zarse
Journal:  Herzschrittmacherther Elektrophysiol       Date:  2008-03

Review 10.  Combined resynchronisation and implantable defibrillator therapy in left ventricular dysfunction: Bayesian network meta-analysis of randomised controlled trials.

Authors:  Simon K H Lam; Andrew Owen
Journal:  BMJ       Date:  2007-10-11
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.